The European Bank for Reconstruction and Development (EBRD) has provided $2.5 million to the American Esper Corporation to expand production capacity for bionic upper limb prostheses in Ukraine as part of the Elysium project.
According to the EBRD press release, the total cost of the project is $6.25 million.
The project is co-financed by a European venture capital fund specializing in medical technology and an American venture capital fund specializing in investments in Ukraine and Moldova.
Esper Corporation is a manufacturer of bionic upper limb prostheses with research and production facilities located in Ukraine.
The main owners of Esper are Ukrainian entrepreneurs.
Related:
